This study is aimed to evaluate the impact of Benzo (f) chromen-3-one, a plant compound present in Artemisia vulgaris, which was retrieved from pubchem database, as a NF-κB inhibitor, a key regulator found to be chronically activated in various ailments, such as Cancer, Diabetes, Rheumatoid Arthritis, Alzheimers and Inflammation etc. Molecular properties of the compound were analysed using Molinspiration and Swiss ADME servers. Molecular docking studies were performed followed by pathway analysis using STRING and KEGG databases. Docking results indicate grater binding affinity of the compound with NF-κB molecule. Molecular properties of the compound are in agreement with the Lipinski rule of five and also possess good pharmacological properties. Pathway analyses clarify the connecting link between various ailments in inflammation induced disease pathogenesis. Our computational analysis rationalizes the inhibitory ability of naturally occurring plant compound to alter the NF-κB signalling pathway. Docking studies substantiates the hypothesis that Benzo (f) chromen-3-one has significant potential to inhibit the NF-κB.
Key words: Benzo (f) chromen-3-one, NF-κB, Molecular docking, inflammation.